Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis:
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
2015
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | Aus: Multiple Sclerosis Journal 21.14 (2015): S. 1823-1832. <http://journals.sagepub.com/doi/full/10.1177/1352458515576984> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. |
| Beschreibung: | Online-Ressource |
| Format: | Langzeitarchivierung gewährleistet, LZA |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044262830 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 170406s2015 gw |||| o||u| ||||||eng d | ||
| 015 | |a 17,O03 |2 dnb | ||
| 016 | 7 | |a 1124683283 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-81728 |2 urn | |
| 035 | |a (OCoLC)992514646 | ||
| 035 | |a (DE-599)DNB1124683283 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 082 | 0 | |a 610 |2 23 | |
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Kohlmann, Rebekka |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis |c Rebekka Kohlmann, Anke Salmen, Andrew Chan, Cornelius Knabbe, Jürgen Diekmann, Norbert Brockmeyer, Adriane Skaletz-Rorowski, Claudia Michalik, Ralf Gold, Klaus Überla |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |c 2015 | |
| 300 | |a Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Aus: Multiple Sclerosis Journal 21.14 (2015): S. 1823-1832. <http://journals.sagepub.com/doi/full/10.1177/1352458515576984> | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. | ||
| 500 | |a This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. | ||
| 538 | |a Langzeitarchivierung gewährleistet, LZA | ||
| 653 | |a Adverse events | ||
| 653 | |a antibodies | ||
| 653 | |a autoimmune disease | ||
| 653 | |a blood donors | ||
| 653 | |a herpes zoster | ||
| 653 | |a human immunodeficiency virus | ||
| 653 | |a immunosuppression | ||
| 653 | |a JC virus | ||
| 653 | |a multiple sclerosis | ||
| 653 | |a natalizumab | ||
| 653 | |a neurotropic virus | ||
| 653 | |a risk factors | ||
| 653 | |a subclinical reactivation | ||
| 653 | |a varicella-zoster virus | ||
| 653 | |a virus reactivation | ||
| 700 | 1 | |a Salmen, Anke |e Verfasser |4 aut | |
| 700 | 1 | |a Chan, Andrew |e Verfasser |4 aut | |
| 700 | 1 | |a Knabbe, Cornelius |e Verfasser |4 aut | |
| 700 | 1 | |a Diekmann, Jürgen |e Verfasser |4 aut | |
| 700 | 1 | |a Brockmeyer, Norbert |e Verfasser |4 aut | |
| 700 | 1 | |a Skaletz-Rorowski, Adriane |d 1963- |e Verfasser |0 (DE-588)172583306 |4 aut | |
| 700 | 1 | |a Michalik, Claudia |e Verfasser |4 aut | |
| 700 | 1 | |a Gold, Ralf |e Verfasser |4 aut | |
| 700 | 1 | |a Überla, Klaus |e Verfasser |4 aut | |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-81728 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1124683283/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/8172 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029667706 | ||
Datensatz im Suchindex
| _version_ | 1804177440946257920 |
|---|---|
| any_adam_object | |
| author | Kohlmann, Rebekka Salmen, Anke Chan, Andrew Knabbe, Cornelius Diekmann, Jürgen Brockmeyer, Norbert Skaletz-Rorowski, Adriane 1963- Michalik, Claudia Gold, Ralf Überla, Klaus |
| author_GND | (DE-588)172583306 |
| author_facet | Kohlmann, Rebekka Salmen, Anke Chan, Andrew Knabbe, Cornelius Diekmann, Jürgen Brockmeyer, Norbert Skaletz-Rorowski, Adriane 1963- Michalik, Claudia Gold, Ralf Überla, Klaus |
| author_role | aut aut aut aut aut aut aut aut aut aut |
| author_sort | Kohlmann, Rebekka |
| author_variant | r k rk a s as a c ac c k ck j d jd n b nb a s r asr c m cm r g rg k ü kü |
| building | Verbundindex |
| bvnumber | BV044262830 |
| collection | ebook |
| ctrlnum | (OCoLC)992514646 (DE-599)DNB1124683283 |
| dewey-full | 610 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610 |
| dewey-search | 610 |
| dewey-sort | 3610 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03020nmm a2200697zc 4500</leader><controlfield tag="001">BV044262830</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">170406s2015 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">17,O03</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1124683283</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-81728</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)992514646</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1124683283</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kohlmann, Rebekka</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis</subfield><subfield code="c">Rebekka Kohlmann, Anke Salmen, Andrew Chan, Cornelius Knabbe, Jürgen Diekmann, Norbert Brockmeyer, Adriane Skaletz-Rorowski, Claudia Michalik, Ralf Gold, Klaus Überla</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Aus: Multiple Sclerosis Journal 21.14 (2015): S. 1823-1832. <http://journals.sagepub.com/doi/full/10.1177/1352458515576984></subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively.</subfield></datafield><datafield tag="538" ind1=" " ind2=" "><subfield code="a">Langzeitarchivierung gewährleistet, LZA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Adverse events</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antibodies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autoimmune disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blood donors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">herpes zoster</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human immunodeficiency virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunosuppression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">JC virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multiple sclerosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">natalizumab</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurotropic virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">risk factors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">subclinical reactivation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">varicella-zoster virus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virus reactivation</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Salmen, Anke</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chan, Andrew</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Knabbe, Cornelius</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Diekmann, Jürgen</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Brockmeyer, Norbert</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Skaletz-Rorowski, Adriane</subfield><subfield code="d">1963-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)172583306</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Michalik, Claudia</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gold, Ralf</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Überla, Klaus</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-81728</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1124683283/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/8172</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029667706</subfield></datafield></record></collection> |
| id | DE-604.BV044262830 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:48:07Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029667706 |
| oclc_num | 992514646 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | Online-Ressource |
| psigel | ebook |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
| record_format | marc |
| spelling | Kohlmann, Rebekka Verfasser aut Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis Rebekka Kohlmann, Anke Salmen, Andrew Chan, Cornelius Knabbe, Jürgen Diekmann, Norbert Brockmeyer, Adriane Skaletz-Rorowski, Claudia Michalik, Ralf Gold, Klaus Überla Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) 2015 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Aus: Multiple Sclerosis Journal 21.14 (2015): S. 1823-1832. <http://journals.sagepub.com/doi/full/10.1177/1352458515576984> Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence or a national licence (funded by the DFG, German Research Foundation) respectively. Langzeitarchivierung gewährleistet, LZA Adverse events antibodies autoimmune disease blood donors herpes zoster human immunodeficiency virus immunosuppression JC virus multiple sclerosis natalizumab neurotropic virus risk factors subclinical reactivation varicella-zoster virus virus reactivation Salmen, Anke Verfasser aut Chan, Andrew Verfasser aut Knabbe, Cornelius Verfasser aut Diekmann, Jürgen Verfasser aut Brockmeyer, Norbert Verfasser aut Skaletz-Rorowski, Adriane 1963- Verfasser (DE-588)172583306 aut Michalik, Claudia Verfasser aut Gold, Ralf Verfasser aut Überla, Klaus Verfasser aut https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-81728 Resolving-System kostenfrei Volltext http://d-nb.info/1124683283/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/8172 Verlag kostenfrei Volltext |
| spellingShingle | Kohlmann, Rebekka Salmen, Anke Chan, Andrew Knabbe, Cornelius Diekmann, Jürgen Brockmeyer, Norbert Skaletz-Rorowski, Adriane 1963- Michalik, Claudia Gold, Ralf Überla, Klaus Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis |
| title | Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis |
| title_auth | Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis |
| title_exact_search | Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis |
| title_full | Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis Rebekka Kohlmann, Anke Salmen, Andrew Chan, Cornelius Knabbe, Jürgen Diekmann, Norbert Brockmeyer, Adriane Skaletz-Rorowski, Claudia Michalik, Ralf Gold, Klaus Überla |
| title_fullStr | Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis Rebekka Kohlmann, Anke Salmen, Andrew Chan, Cornelius Knabbe, Jürgen Diekmann, Norbert Brockmeyer, Adriane Skaletz-Rorowski, Claudia Michalik, Ralf Gold, Klaus Überla |
| title_full_unstemmed | Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis Rebekka Kohlmann, Anke Salmen, Andrew Chan, Cornelius Knabbe, Jürgen Diekmann, Norbert Brockmeyer, Adriane Skaletz-Rorowski, Claudia Michalik, Ralf Gold, Klaus Überla |
| title_short | Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis |
| title_sort | serological evidence of increased susceptibility to varicella zoster virus reactivation or reinfection in natalizumab treated patients with multiple sclerosis |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-81728 http://d-nb.info/1124683283/34 https://open.fau.de/handle/openfau/8172 |
| work_keys_str_mv | AT kohlmannrebekka serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT salmenanke serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT chanandrew serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT knabbecornelius serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT diekmannjurgen serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT brockmeyernorbert serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT skaletzrorowskiadriane serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT michalikclaudia serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT goldralf serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis AT uberlaklaus serologicalevidenceofincreasedsusceptibilitytovaricellazostervirusreactivationorreinfectioninnatalizumabtreatedpatientswithmultiplesclerosis |